VACBF

Stock ticker: OTC

PRICE

CHANGE

CAPITALIZATION

NYKODE THERAPEUTICS AS (VACBF) Ownership - Who owns NYKODE THERAPEUTICS AS?

Nykode Therapeutics AS is a clinical-stage biopharmaceutical company focused on the discovery and development of novel immunotherapies... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

Gaustadalleen 21

Phone

+47 22958193

Employees

155

Web

https://www.nykode.com

Details

Group

Domestic Stock Funds

Fundamentals

VACBF

Capitalization

67.3M

P/E Ratio

N/A

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash

115M

Total Cash/Share

0.35

Total Debt

3.44M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

0.03%

Revenue

8.68M

ROE

N/A

Book Value

136M

P/B Ratio

0.52

Cash Flow

N/A

Earnings

-0.12

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

367K

Current Ratio

12.87

Current Revenue Per Employee

48726.62

Dividends Per Share - Security

N/A

EBITDA

-43.07M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

-21.47

Shares Held By Institutions

80.3M

Shares Outstanding - Current

327M

Total Liabilities

17.3M

Total Volume MTD

N/A

Value

Gain YTD

-9.884

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology